Buy HUMULIN 30/70 CARTRIDGE 30 UNIT INSULIN INJECTION HUMAN BIOSYNTHETIC

HUMULIN 30/70 CARTRIDGE 30 UNIT is a human biosynthetic insulin suspension designed for subcutaneous administration. It combines rapid-acting and intermediate-acting insulin for blood glucose management. Ideal for those requiring flexible insulin therapy.

Strength

30 UNIT

Pack Size

3ML

Manufacturer / TM Owner

ELI LILLY CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

HUMULIN 30/70 CARTRIDGE 30 UNIT is used for managing blood glucose levels in individuals with diabetes. This insulin suspension provides both immediate and prolonged effects, making it suitable for daily glucose control. It is often prescribed to help regulate insulin levels in diabetic patients.

Side Effects

Common effects of HUMULIN 30/70 CARTRIDGE 30 UNIT may include localized reactions at the injection site, such as redness or swelling. Some users may experience hypoglycemia if not properly managed. Always follow healthcare provider instructions for optimal results.

Precautions & Warnings

Handle HUMULIN 30/70 CARTRIDGE 30 UNIT with care, ensuring it is stored properly to maintain its efficacy. Check the cartridge for any visible particles or discoloration before use. Always use a new needle for each injection to prevent contamination.

Avoid Interactions

HUMULIN 30/70 CARTRIDGE 30 UNIT may interact with other medications, including oral hypoglycemic agents and certain antihypertensive drugs. Alcohol and other substances that affect blood glucose levels should be consumed with caution. Consult a healthcare provider for personalized advice.

References

Frequently Asked Questions

HUMULIN 30/70 CARTRIDGE 30 UNIT is used to manage blood glucose levels in individuals with diabetes, providing both immediate and prolonged insulin effects.

Store HUMULIN 30/70 CARTRIDGE 30 UNIT in a refrigerator between 2°C to 8°C, protecting it from light and heat. Do not freeze the cartridge.

Common side effects may include localized reactions at the injection site, such as redness or swelling, and hypoglycemia if not properly managed.

HUMULIN 30/70 CARTRIDGE 30 UNIT may interact with other medications, including oral hypoglycemic agents and certain antihypertensive drugs. Consult a healthcare provider for personalized advice.

Always use a new needle for each injection to prevent contamination and ensure proper administration.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.